Evermay Wealth Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$85.7K Hold
290
0.01% 270
2025
Q4
$79.2K Hold
290
0.01% 278
2025
Q3
$78.4K Sell
290
-110
-28% -$29.9K 0.01% 292
2025
Q2
$110K Buy
400
+50
+14% +$13.6K 0.01% 254
2025
Q1
$92.9K Hold
350
0.01% 269
2024
Q4
$81.3K Hold
350
0.01% 275
2024
Q3
$77.2K Sell
350
-36
-9% -$7.45K 0.01% 295
2024
Q2
$75.9K Hold
386
0.01% 302
2024
Q1
$83.1K Sell
386
-3
-0.8% -$630 0.01% 301
2023
Q4
$84K Sell
389
-152
-28% -$32.4K 0.02% 271
2023
Q3
$108K Hold
541
0.02% 226
2023
Q2
$100K Buy
541
+36
+7% +$6.65K 0.02% 244
2023
Q1
$96.7K Buy
505
+5
+1% +$904 0.02% 241
2022
Q4
$84.1K Sell
500
-50
-9% -$8.69K 0.02% 240
2022
Q3
$97K Hold
550
0.02% 220
2022
Q2
$113K Buy
550
+40
+8% +$8.48K 0.02% 209
2022
Q1
$121K Hold
510
0.02% 237
2021
Q4
$117K Hold
510
0.02% 216
2021
Q3
$99K Hold
510
0.02% 216
2021
Q2
$108K Buy
+510
New +$108K 0.02% 217

Other funds holding CME

Evermay Wealth Management's CME Position: Q1 2026 in Review

Evermay Wealth Management held its CME Group (CME) position steady in Q1 2026 at 290 shares worth $85.7K. The position accounts for 0.01% of the portfolio, ranked #270.

Evermay Wealth Management first reported a position in CME in Q2 2021 and has held it in 20 quarters since. The position peaked at $121K in Q1 2022. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Evermay Wealth Management held 290 shares of CME Group worth $85.7K as of Q1 2026.
  • Evermay Wealth Management left its CME Group share count unchanged in Q1 2026.
  • CME Group made up 0.01% of Evermay Wealth Management's portfolio in Q1 2026, its #270 holding.
  • Evermay Wealth Management first reported a position in CME Group in Q2 2021 and has held it in 20 quarters since.
  • Evermay Wealth Management's CME Group position peaked at $121K in Q1 2022.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Evermay Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.